Level B· Emerging clinical evidence with positive signalsClinical TrialPubMed

Exosomes in Aesthetic Medicine: An Overview.

Duncan DI., Tiryaki T., Suwanchinda A., Chernoff G., Cohen S.

Clinical Trial on Chronic Wound, Scar, Skin Aging, Immune Modulation, published in Aesthet Surg J (2026) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Aesthet Surg J (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41800722
DOI
10.1093/asj/sjaf259

Abstract (original English)

The use of exosomes in regenerative aesthetics represents a conceptual shift. Although stem cells operate using an engraftment and differentiation method, exosomes mediate therapeutic effects through transfer of bioactive molecules that orchestrate regenerative cascades. These tiny particles have evolved from their initial characterization as cellular waste repositories to critical mediators of physiological processes. Laboratory research and clinical trials position exosomes as tailored biological messengers with tissue-specific tropism and immunomodulatory capabilities. Sourcing diversity, ranging from mesenchymal stem cells to immune cells and platelets, imparts distinct molecular signatures that determine therapeutic potential. Contemporary isolation techniques have progressed from ultracentrifugation to more sophisticated approaches yielding variable purity profiles. Regulatory frameworks span Section 351 of the Public Health Service Act governing minimally manipulated preparations, Section 361 therapeutics with specific drug indications, and Federal Food, Drug, and Cosmetic Act-regulated topical formulations, with international approaches varying significantly across jurisdictions. Clinical applications include photoaging remediation, scar remodeling, hair follicle regeneration, wound healing, postprocedure recovery and adipose tissue volumization, with mechanisms encompa

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansExosomesCosmetic TechniquesRegenerative MedicineWound HealingAnimalsRegenerationRejuvenationSkin Aging

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research